CXCR3 and neoplasm: This apparent contradiction reframes the central question from a simplistic good-versus-bad dichotomy into a complex spatiotemporal puzzle: how does high systemic CXCL10—an indicator of poor prognosis—arise, and by what mechanism does it subvert the established anti-tumor functions of the local CXCL10-CXCR3 axis?